Pamorelin LA 22.5 Injection Information

Pamorelin LA 22.5 Injection, a prescription drug, is manufactured in various forms such as Injection. It is primarily used for the treatment of Prostate Cancer. Other than this, Pamorelin LA 22.5 Injection has some other therapeutic uses, which have been discussed ahead.

Medical history of the patient along with age and gender determines the dosage of Pamorelin LA 22.5 Injection. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.

Pamorelin LA 22.5 Injection also has some side effects, the most common being Excessive sweating, Paresthesia. Apart from the aforementioned side effects, Pamorelin LA 22.5 Injection can also lead to other problems, which have been listed below. Usually, these side effects of Pamorelin LA 22.5 Injection go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.

Pamorelin LA 22.5 Injection's effect during pregnancy is Severe and Severe while nursing. It is important to know if Pamorelin LA 22.5 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pamorelin LA 22.5 Injection related warnings section.

The section on Pamorelin LA 22.5 Injection contraindications lists all such conditions.

Additionally, Pamorelin LA 22.5 Injection may also adversely react with other medicines. Refer to the list below for further details.

Along with the above-mentioned precautions, remember that taking Pamorelin LA 22.5 Injection is considered not safe while driving, and is not addictive.

Pamorelin La Benefits & Uses
Pamorelin La Dosage & How to Take
Pamorelin La Side Effects
Pamorelin La Related Warnings
Pamorelin La Contraindications
Frequently asked Questions about Pamorelin La
Pamorelin La Interactions with Food and Alcohol

Pamorelin LA 22.5 Injection Benefits & Uses

Pamorelin LA 22.5 Injection is used to treat the following -

Other Benefits

Prostate Cancer

Pamorelin LA 22.5 Injection Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult(Male)	Disease: Prostate Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 22.5 mg Dosage Route: Parenteral Frequency: doctor administered Course Duration: As directed by the doctor Special Instructions: dose should be given once every 24 weeks
Geriatric	Disease: Prostate Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 22.5 mg Dosage Route: Parenteral Frequency: doctor administered Course Duration: As directed by the doctor Special Instructions: dose should be given once every 24 weeks
13 - 18 years (Adolescent)	Disease: Precocious Puberty Before or After Meal: As advised by a physician Single Maximum Dose: 22.5 mg Dosage Route: Parenteral Frequency: doctor administered Course Duration: As directed by the doctor Special Instructions: dose should be given once every 24 weeks
2 - 12 years (Child)	Disease: Precocious Puberty Before or After Meal: As advised by a physician Single Maximum Dose: 22.5 mg Dosage Route: Parenteral Frequency: doctor administered Course Duration: As directed by the doctor Special Instructions: dose should be given once every 24 weeks

Pamorelin LA 22.5 Injection Related Warnings

Is the use of Pamorelin LA 22.5 Injection safe for pregnant women?

Pamorelin LA should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.

Severe
Is the use of Pamorelin LA 22.5 Injection safe during breastfeeding?

Taking Pamorelin LA may lead to serious side effects if you are breastfeeding. Pamorelin LA should not be taken by breastfeeding women unless prescribed by the doctor.

Severe
What is the effect of Pamorelin LA 22.5 Injection on the Kidneys?

Very few cases of side effects of Pamorelin LA on kidney have been reported.

Mild
What is the effect of Pamorelin LA 22.5 Injection on the Liver?

Pamorelin LA is rarely harmful for the liver.

Mild
What is the effect of Pamorelin LA 22.5 Injection on the Heart?

Pamorelin LA may have severe effects on your heart, so do not take it without first consulting your doctor.

Severe

Pamorelin LA 22.5 Injection Contraindications

If you are suffering from any of the following diseases, you should not take Pamorelin LA 22.5 Injection unless your doctor advises you to do so -

Diabetes
High Cholesterol
High Blood Pressure
Heart Failure
Liver Disease
Stroke
Kidney Disease
Heart Disease

Frequently asked Questions about Pamorelin LA 22.5 Injection

Is this Pamorelin LA 22.5 Injection habit forming or addictive?

No, you will not get addicted to Pamorelin LA 22.5 Injection.

No
Is it safe to drive or operate heavy machinery when consuming?

No, you should do not do anything that requires concentration and attention as the Pamorelin LA 22.5 Injection can make you feel drowsy.

Dangerous
Is it safe?

Yes, but consume Pamorelin LA 22.5 Injection only on doctor's advice.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

There is no benefit of taking Pamorelin LA 22.5 Injection for mental disorders.

No

Pamorelin LA 22.5 Injection Interactions with Food and Alcohol

Interaction between Food and Pamorelin LA 22.5 Injection

Due to a lack of research, nothing can be said about the consequences of taking Pamorelin LA 22.5 Injection together with food.

Unknown
Interaction between Alcohol and Pamorelin LA 22.5 Injection

Information about the interaction of Pamorelin LA 22.5 Injection and alcohol is not currently available because this topic has not been researched yet.

Unknown

See all substitutes for Pamorelin La

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 53

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 242-243

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trelstar® (triptorelin pamoate)

Pamorelin LA 22.5 Injection